Table 5 Medication use in home hemodialysis patients
| Â | Baseline | Month 3 | Month 6 | P a |
|---|---|---|---|---|
Antihypertensive medication use (agents/day) | ||||
 Mean (SD) | 1.46 (1.49) | 1.10 (1.29) | 1.01 (1.11) | < 0.001 |
 Median (IQR) | 1 (2) | 1 (1) | 1 (1) |  |
 10th–90th percentile interval | 0–4 | 0–3 | 0–3 |  |
Phosphate binder use (pills/day) | ||||
 Mean (SD) | 3.25 (2.91) | 3.13 (2.66) | 3.21 (2.84) | 0.83 |
 Median (IQR) | 3 (4) | 3 (3) | 3 (5) |  |
 10th–90th percentile interval | 0–6 | 0–6 | 0–6 |  |
ESA dose (EPO-equivalent IU/week) | ||||
 Mean (SD) | 8792 (6936) | 8211 (6654) | 8551 (7086) | 0.57 |
 Median (IQR) | 8000 (6000) | 7750 (6000) | 8000 (8000) |  |
 10th–90th percentile interval | 2000–17,000 | 1250–16,000 | 0–16,125 |  |
Anticoagulant use b (%) | ||||
 No | 21.4 | NR | 40.2 | < 0.001 |
 Yes | 78.6 | NR | 59.8 |  |